These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress. Auton M; Sowa KE; Smith SM; Sedlák E; Vijayan KV; Cruz MA J Biol Chem; 2010 Jul; 285(30):22831-9. PubMed ID: 20498367 [TBL] [Abstract][Full Text] [Related]
43. Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndrome. Béguin S; Keularts I; Al Dieri R; Bellucci S; Caen J; Hemker HC J Thromb Haemost; 2004 Jan; 2(1):170-6. PubMed ID: 14717981 [TBL] [Abstract][Full Text] [Related]
44. von Willebrand factor competes with fibrin for occupancy of GPIIb:IIIa on thrombin-stimulated platelets. Hantgan RR; Nichols WL; Ruggeri ZM Blood; 1990 Feb; 75(4):889-94. PubMed ID: 2302458 [TBL] [Abstract][Full Text] [Related]
45. Function of von Willebrand factor in haemostasis and thrombosis. Reininger AJ Haemophilia; 2008 Nov; 14 Suppl 5():11-26. PubMed ID: 18786007 [TBL] [Abstract][Full Text] [Related]
46. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets. Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222 [TBL] [Abstract][Full Text] [Related]
47. Fibrin monomer induces binding of endogenous platelet von Willebrand factor to the glycocalicin portion of platelet glycoprotein IB. Parker RI; Gralnick HR Blood; 1987 Nov; 70(5):1589-94. PubMed ID: 3499190 [TBL] [Abstract][Full Text] [Related]
48. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. Goto S; Salomon DR; Ikeda Y; Ruggeri ZM J Biol Chem; 1995 Oct; 270(40):23352-61. PubMed ID: 7559492 [TBL] [Abstract][Full Text] [Related]
49. Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans. Madabhushi SR; Zhang C; Kelkar A; Dayananda KM; Neelamegham S J Am Heart Assoc; 2014 Oct; 3(5):e001420. PubMed ID: 25341886 [TBL] [Abstract][Full Text] [Related]
50. Identification of a juxtamembrane mechanosensitive domain in the platelet mechanosensor glycoprotein Ib-IX complex. Zhang W; Deng W; Zhou L; Xu Y; Yang W; Liang X; Wang Y; Kulman JD; Zhang XF; Li R Blood; 2015 Jan; 125(3):562-9. PubMed ID: 25359992 [TBL] [Abstract][Full Text] [Related]
51. [Involvement of platelet collagen receptors in primary hemostasis]. Kralisz U; Stasiak M Postepy Biochem; 2007; 53(4):344-55. PubMed ID: 19024899 [TBL] [Abstract][Full Text] [Related]
52. Laboratory Testing for von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb). Patzke J; Favaloro EJ Methods Mol Biol; 2017; 1646():453-460. PubMed ID: 28804847 [TBL] [Abstract][Full Text] [Related]
53. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa. De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830 [TBL] [Abstract][Full Text] [Related]
54. Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl(3)-induced occlusive thrombus formation in the inferior vena cava of mice. Joglekar MV; Ware J; Xu J; Fitzgerald ME; Gartner TK Platelets; 2013; 24(3):205-12. PubMed ID: 22720736 [TBL] [Abstract][Full Text] [Related]
55. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val. Doggett TA; Girdhar G; Lawshe A; Miller JL; Laurenzi IJ; Diamond SL; Diacovo TG Blood; 2003 Jul; 102(1):152-60. PubMed ID: 12637314 [TBL] [Abstract][Full Text] [Related]
56. 14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling. Chen Y; Ruggeri ZM; Du X Blood; 2018 May; 131(22):2436-2448. PubMed ID: 29622550 [TBL] [Abstract][Full Text] [Related]
57. Shear stress-induced binding of von Willebrand factor to platelets. Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590 [TBL] [Abstract][Full Text] [Related]
58. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets. Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125 [TBL] [Abstract][Full Text] [Related]
59. Critical role of von Willebrand factor and platelet interaction in venous thromboembolism. Takahashi M; Yamashita A; Moriguchi-Goto S; Marutsuka K; Sato Y; Yamamoto H; Koshimoto C; Asada Y Histol Histopathol; 2009 Nov; 24(11):1391-8. PubMed ID: 19760588 [TBL] [Abstract][Full Text] [Related]
60. Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3). Yap CL; Anderson KE; Hughan SC; Dopheide SM; Salem HH; Jackson SP Blood; 2002 Jan; 99(1):151-8. PubMed ID: 11756165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]